Table 5.
Intestinal immune and inflammatory response to influence of NE challenge and modulation effect by probiotics.
Response to NE Challenge | Response to Dietary Probiotics | |||||
---|---|---|---|---|---|---|
S/N | Intestinal Immunity | Intestinal Inflammation | Probiotic Strains | Intestinal Immunity | Intestinal Inflammation | Ref |
1 | Reduced expression of IgA and IgG; increased PGC-1a expression | NE | B. licheniformis H2 | Increased IgA and IgG; reduced expression of PGC-1a | NE | [12] |
2 | Decreased immunoglobulins and T helper: Th cells in the cecal tonsils | Increased IL-1B | Multi strains of Lactobacillus | Increased immunoglobulins and T cells. Reduced sIgA | Increased IFN-γ, IL-13 and IL-2; reduced IL-1B, IL-12p35, IL-17 and TGF-B | [13] |
3 | Decreased jejunal mRNA TRIF and NF-KB | Changes in IL-1β, IL-10, IL-17 and TNF-α | B. licheniformis | Increased jejunal mRNA TRIF and NF-KB; no effect on TLR2 or TLR4 | No effect on IL-1β, IL-10, IL-17 or TNF-α; increased GFs and HSP proteins | [19] |
4 | Increased FITC and intestinal IgA | NE | B. licheniformis H2 | Increased the contents | NE | [21] |
5 | Increased sIgA | Increased IFN-γ | B. licheniformis | Reduced sIgA | Reduced IFN-γ, IL-10 and IL-17 | [23] |
6 | Reduced sIgA, TLR2, TLR4 and TNFSF15 Fowlcidin gene | Increased IFN-γ. Decreased TLR2, TLR4 and TNFSF15 gene | B. coagulans | Increased sIgA; no effect on TLRsl only increased fowlcidin-2 | Reduced IFN-γ; no effect on others | [25] |
7 | Reduced TLR2 | No effect on TNF or TLR2; increased IL-17 | C. butyricum | No effect on intestinal IgA | Increased TNF-α, IL-10, reduced IL-17A | [26] |
8 | NE | Increased (chTNF-α) and IL-1β in the ileum mucosa | L. plantarum 1.2567 | NE | Reduced (chTNF-α) and IL-1β | [30] |
9 | Reduced populationof CD3+ | Increased jejunal IL-1β and TGF-β4 by 28. Both increased | L. fermentum, B. coagulans | Increased CD3 | Increased and reduced IL-1β, INF-γ, IL-13,1L-17 and TGF-B. | [33] |
10 | NE | Increased IL-6, TNF-a and IFN-γ | B. subtilis DSM 32315. | NE | Reduced IL-6, TNF-α and IFN-γ and increased IL-10 and SIgA | [52] |
11 | Reduced ileum IgA and IgG, sIgA and content. Increased MMP-2 | Increased IFN-γ and IL-10 | Lactobacillus johnsonii BS15 | Increased the IgA, IgG and sIgA content; reduced MMP-2 | Reduced IFN-γ and IL-10; increased Nrf-2 and IL-8. | [70] |
12 | NE | Reduced IL-10 and IL-17 | Primlac:multi strain | NE | Increased IL-10 and IL-17 | [94] |
13 | Reduced serum sIgA and IgG | Increased IL-1β, TNF-α, INF-γ and IL-6 | B. subtilis DSM29784 | No effect on sIgA | Reduced IFN-γ and TNF- α | [95] |
14 | Reduced sIgA | Increased IFN-γ, IL-10 and IL-6 | B. amyloliquefaciens BLCC1-0238 | Increased sIgA | Decreased IFN-γ, IL-10 and IL-6 | [110] |
15 | NE | Reduced TLR-2, IL-1β, IL-4, IFN-γ, iNOS and IL-10 | E. faecium | Increased MYD88, NFK-B, IL-1β, IL-4 and iNOS | [112] | |
16 | Reduced serum IgG and IgA, CD3+, CD4+ and lymphocyte percentage | Reduced IL-2, IL-4 and IFN-γ | L. johnsonii BS15 | Increased the IgG and IgA and CD+ cells | Increased IFN-γ and IL-2 | [114] |
17 | Reduced serum IgG and IgM | No effect on IL-6, TNF-α or IFN-γ | L. johnsonii BS15, Bacillus | Increased serum IgG and IgM | No effect on IL-6, TNF-α or IFN-γ but reduced IL-8 | [116] |
18 | Reduced TLR21 | Reduced INF-γ, IL-12 and TGF-B4 | B. subtilis 29,784 | Increased TLR21 after infection and TLR 5 | Increased INF-γ, IL-12 and TGF-B4 | [122] |